Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7th immunorad conference.
Laurent PA, André F, Bobard A, Deandreis D, Demaria S, Depil S, Eichmüller SB, Fernandez-Palomo C, Foijer F, Galluzzi L, Galon J, Guckenberger M, Harrington KJ, Herrera FG, Huber PE, Italiano A, Karam SD, Kroemer G, Lambin P, Leuschner C, Mantovani A, Meylan E, Mondini M, Pittet MJ, Pouget JP, Remon J, Sørensen CS, Sotiriou C, Vanpouille-Box C, Weichselbaum RR, Welsh JW, Zitvogel L, Formenti SC, Deutsch E. Laurent PA, et al. Among authors: pouget jp. Oncoimmunology. 2025 Dec;14(1):2432726. doi: 10.1080/2162402X.2024.2432726. Epub 2024 Dec 18. Oncoimmunology. 2025. PMID: 39696783 Free PMC article.
Immunostimulatory effects of radioimmunotherapy.
Constanzo J, Galluzzi L, Pouget JP. Constanzo J, et al. Among authors: pouget jp. J Immunother Cancer. 2022 Feb;10(2):e004403. doi: 10.1136/jitc-2021-004403. J Immunother Cancer. 2022. PMID: 35190377 Free PMC article.
EANM expert opinion: How can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses.
Pouget JP, Gabina PM, Herrmann K, Deandreis D, Konijnenberg M, Taieb D, van Leeuwen FWB, Kurth J, Eberlein U, Lassmann M, Lückerath K; EANM Radiobiology Working Group. Pouget JP, et al. Eur J Nucl Med Mol Imaging. 2024 Nov 12. doi: 10.1007/s00259-024-06963-9. Online ahead of print. Eur J Nucl Med Mol Imaging. 2024. PMID: 39531084 Review.
Status of radiobiology in molecular radionuclide therapy - Hope for the future.
Nonnekens J, Pouget JP, Cornelissen B, Terry SYA; European Working Group; Radiobiology of Molecular Radionuclide Therapy. Nonnekens J, et al. Among authors: pouget jp. Nucl Med Biol. 2022 Jul-Aug;110-111:45-46. doi: 10.1016/j.nucmedbio.2022.04.008. Epub 2022 Apr 16. Nucl Med Biol. 2022. PMID: 35561638 No abstract available.
General overview of radioimmunotherapy of solid tumors.
Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP. Navarro-Teulon I, et al. Among authors: pouget jp. Immunotherapy. 2013 May;5(5):467-87. doi: 10.2217/imt.13.34. Immunotherapy. 2013. PMID: 23638743 Review.
Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies.
Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, Derocq D, Robin G, Michaud HA, Delpech H, Jarlier M, Pugnière M, Robert B, Puel A, Martin L, Landomiel F, Bourquard T, Achour O, Fruitier-Arnaudin I, Pichard A, Deshayes E, Turtoi A, Poupon A, Simony-Lafontaine J, Boissière-Michot F, Pirot N, Bernex F, Jacot W, du Manoir S, Theillet C, Pouget JP, Navarro-Teulon I, Bonnefoy N, Pèlegrin A, Chardès T, Martineau P, Liaudet-Coopman E. Ashraf Y, et al. Among authors: pouget jp. J Immunother Cancer. 2019 Feb 4;7(1):29. doi: 10.1186/s40425-019-0498-z. J Immunother Cancer. 2019. PMID: 30717773 Free PMC article.
120 results